$23.99
Insights on Huntsman Corporation
Revenue is down for the last 8 quarters, 2.38B → 1.40B (in $), with an average decrease of 7.1% per quarter
Netprofit is down for the last 2 quarters, 69.0M → -71.0M (in $), with an average decrease of 202.9% per quarter
In the last 1 year, Celanese Corporation has given 54.6% return, outperforming this stock by 62.2%
In the last 3 years, Huntsman Corporation has experienced a drawdown of -15.3%, however Celanese Corporation resisted the overall trend and outperformed by 14.1%
1.31%
Downside
Day's Volatility :1.46%
Upside
0.15%
9.46%
Downside
52 Weeks Volatility :25.23%
Upside
17.42%
Period | Huntsman Corporation | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -1.88% | 7.1% | 0.0% |
6 Months | 5.78% | 18.6% | 0.0% |
1 Year | -7.59% | 11.1% | 1.3% |
3 Years | -17.02% | 6.5% | -22.1% |
Market Capitalization | 4.2B |
Book Value | $18.95 |
Dividend Share | 0.95 |
Dividend Yield | 4.16% |
Earnings Per Share (EPS) | -0.1 |
PEG Ratio | 1.79 |
Wall Street Target Price | 27.87 |
Profit Margin | 1.65% |
Operating Margin TTM | -3.35% |
Return On Assets TTM | 0.84% |
Return On Equity TTM | 0.96% |
Revenue TTM | 6.1B |
Revenue Per Share TTM | 34.45 |
Quarterly Revenue Growth YOY | -15.0% |
Gross Profit TTM | 1.5B |
EBITDA | 373.0M |
Diluted Eps TTM | -0.1 |
Quarterly Earnings Growth YOY | -0.9 |
EPS Estimate Current Year | 0.5 |
EPS Estimate Next Year | 1.62 |
EPS Estimate Current Quarter | -0.17 |
EPS Estimate Next Quarter | 0.01 |
What analysts predicted
Upside of 16.17%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 9.4B | ↑ 12.22% |
Net Income | 337.0M | ↓ 47.01% |
Net Profit Margin | 3.59% | ↓ 4.02% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 6.8B | ↓ 27.53% |
Net Income | 429.0M | ↑ 27.3% |
Net Profit Margin | 6.31% | ↑ 2.72% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 6.0B | ↓ 11.46% |
Net Income | 291.0M | ↓ 32.17% |
Net Profit Margin | 4.84% | ↓ 1.47% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 8.5B | ↑ 40.46% |
Net Income | 1.0B | ↑ 259.11% |
Net Profit Margin | 12.36% | ↑ 7.52% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 8.0B | ↓ 5.09% |
Net Income | 460.0M | ↓ 55.98% |
Net Profit Margin | 5.73% | ↓ 6.63% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.1B | ↓ 23.83% |
Net Income | 101.0M | ↓ 78.04% |
Net Profit Margin | 1.65% | ↓ 4.08% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.0B | ↓ 14.86% |
Net Income | 100.0M | ↓ 56.14% |
Net Profit Margin | 4.97% | ↓ 4.68% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.7B | ↓ 17.95% |
Net Income | -56.0M | ↓ 156.0% |
Net Profit Margin | -3.39% | ↓ 8.36% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↓ 2.67% |
Net Income | 44.0M | ↓ 178.57% |
Net Profit Margin | 2.74% | ↑ 6.13% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↓ 0.62% |
Net Income | 19.0M | ↓ 56.82% |
Net Profit Margin | 1.19% | ↓ 1.55% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↓ 5.64% |
Net Income | 69.0M | ↑ 263.16% |
Net Profit Margin | 4.58% | ↑ 3.39% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4B | ↓ 6.84% |
Net Income | -71.0M | ↓ 202.9% |
Net Profit Margin | -5.06% | ↓ 9.64% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 8.0B | ↓ 22.36% |
Total Liabilities | 5.2B | ↓ 24.28% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 8.3B | ↑ 4.61% |
Total Liabilities | 5.5B | ↑ 5.61% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 8.7B | ↑ 4.72% |
Total Liabilities | 5.0B | ↓ 8.3% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 9.4B | ↑ 7.79% |
Total Liabilities | 4.8B | ↓ 4.11% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 8.2B | ↓ 12.48% |
Total Liabilities | 4.4B | ↓ 9.37% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 7.2B | ↓ 11.82% |
Total Liabilities | 3.8B | ↓ 13.93% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 8.1B | ↓ 6.75% |
Total Liabilities | 4.1B | ↓ 5.08% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 8.2B | ↑ 1.08% |
Total Liabilities | 4.4B | ↑ 5.59% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.8B | ↓ 5.56% |
Total Liabilities | 3.8B | ↓ 13.86% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.6B | ↓ 2.71% |
Total Liabilities | 3.7B | ↓ 1.75% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.4B | ↓ 2.44% |
Total Liabilities | 3.7B | ↑ 0.22% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.2B | ↓ 1.64% |
Total Liabilities | 3.8B | ↑ 1.48% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2B | ↓ 0.98% |
Investing Cash Flow | -973.0M | ↑ 129.48% |
Financing Cash Flow | -424.0M | ↓ 18.3% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 897.0M | ↓ 25.68% |
Investing Cash Flow | -260.0M | ↓ 73.28% |
Financing Cash Flow | -450.0M | ↑ 6.13% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 253.0M | ↓ 71.79% |
Investing Cash Flow | 1.5B | ↓ 662.69% |
Financing Cash Flow | -655.0M | ↑ 45.56% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 952.0M | ↑ 276.28% |
Investing Cash Flow | -524.0M | ↓ 135.82% |
Financing Cash Flow | -977.0M | ↑ 49.16% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 914.0M | ↓ 3.99% |
Investing Cash Flow | -279.0M | ↓ 46.76% |
Financing Cash Flow | -994.0M | ↑ 1.74% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 288.0M | ↑ 24.68% |
Investing Cash Flow | -59.0M | ↓ 7.81% |
Financing Cash Flow | -296.0M | ↓ 17.09% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 310.0M | ↑ 7.64% |
Investing Cash Flow | -91.0M | ↑ 54.24% |
Financing Cash Flow | -89.0M | ↓ 69.93% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -154.0M | ↓ 149.68% |
Investing Cash Flow | 489.0M | ↓ 637.36% |
Financing Cash Flow | -379.0M | ↑ 325.84% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 40.0M | ↓ 125.97% |
Investing Cash Flow | -49.0M | ↓ 110.02% |
Financing Cash Flow | -85.0M | ↓ 77.57% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 163.0M | ↑ 307.5% |
Investing Cash Flow | 391.0M | ↓ 897.96% |
Financing Cash Flow | -117.0M | ↑ 37.65% |
Sell
Neutral
Buy
Huntsman Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Huntsman Corporation | -5.74% | 5.78% | -7.59% | -17.02% | 5.4% |
Braskem S.a. | -15.14% | 24.29% | 15.64% | -55.53% | -63.35% |
Dow Inc. | -0.71% | 19.86% | 8.53% | -8.39% | 2.98% |
Celanese Corporation | -7.43% | 37.62% | 54.64% | -1.48% | 42.99% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Huntsman Corporation | 46.54 | NA | 1.79 | 0.5 | 0.01 | 0.01 | 0.04 | 18.95 |
Braskem S.a. | 26.15 | NA | -1.31 | -1.48 | -1.04 | 0.0 | NA | 5.01 |
Dow Inc. | 69.2 | 69.2 | 0.78 | 3.02 | 0.03 | 0.03 | 0.05 | 26.5 |
Celanese Corporation | 8.67 | 8.67 | 4.42 | 11.38 | 0.29 | 0.03 | 0.02 | 65.11 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Huntsman Corporation | Hold | $4.2B | 5.4% | 46.54 | 1.65% |
Braskem S.a. | Buy | $3.5B | -63.35% | 26.15 | -6.49% |
Dow Inc. | Hold | $40.2B | 2.98% | 69.2 | 1.32% |
Celanese Corporation | Buy | $17.4B | 42.99% | 8.67 | 17.92% |
Vanguard Group Inc
BlackRock Inc
Dimensional Fund Advisors, Inc.
FMR Inc
Allspring Global Investments Holdings, LLC
Millennium Management LLC
In the quarter ending March,2024. Huntsman Corporation has declared dividend of $0.25
Read Morehuntsman corporation is a publicly traded global manufacturer and marketer of differentiated chemicals with 2014 revenues of approximately $13 billion including the acquisition of rockwood’s performance additives and tio2 businesses. our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. we operate more than 100 manufacturing and r&d facilities in more than 30 countries and employ approximately 16,000 associates within our 5 distinct business divisions. for more information about huntsman, please visit the company's website at www.huntsman.com.
Organization | Huntsman Corporation |
Employees | 6000 |
CEO | Mr. Peter R. Huntsman |
Industry | Process Industries |
Cerevel Therapeutics Holdings Inc
$23.99
-0.17%
Vaxcyte Inc
$23.99
-0.17%
Janux Therapeutics Inc
$23.99
-0.17%
Spdr Nuveen S&p High Yield Municipal Bond Etf
$23.99
-0.17%
Radnet Inc
$23.99
-0.17%
The St. Joe Co
$23.99
-0.17%
Harley-davidson, Inc.
$23.99
-0.17%
Vaneck Vectors Fallen Angel Hiyld Bd Etf
$23.99
-0.17%
Aurora Innovation Inc
$23.99
-0.17%